Terms: = Skin cancer AND NFATC2, ENSG00000101096, 4773, Q13469, NFATP, NFAT1, KIAA0611
18 results:
1. Activation of NFAT by HGF and IGF-1 via ARF6 and its effector ASAP1 promotes uveal melanoma metastasis.
Richards JR; Shin D; Pryor R; Sorensen LK; Sun Z; So WM; Park G; Wolff R; Truong A; McMahon M; Grossmann AH; Harbour JW; Zhu W; Odelberg SJ; Yoo JH
Oncogene; 2023 Aug; 42(35):2629-2640. PubMed ID: 37500798
[TBL] [Abstract] [Full Text] [Related]
2. Treatment Options for Multinucleate Cell Angiohistiocytoma: A Case Series and Review of the Literature.
Taibo A; Padin CP; Losada JDP; Fonseca E
J Cutan Med Surg; 2023; 27(3):219-225. PubMed ID: 36927096
[TBL] [Abstract] [Full Text] [Related]
3. PARP1 Is a Prognostic Marker and Targets nfatc2 to Promote Carcinogenesis in Melanoma.
Mou K; Zhou Y; Mu X; Zhang J; Wang L; Ge R
Genet Test Mol Biomarkers; 2022 Nov; 26(11):503-511. PubMed ID: 36394458
[No Abstract] [Full Text] [Related]
4. Robust gene expression programs underlie recurrent cell states and phenotype switching in melanoma.
Wouters J; Kalender-Atak Z; Minnoye L; Spanier KI; De Waegeneer M; Bravo González-Blas C; Mauduit D; Davie K; Hulselmans G; Najem A; Dewaele M; Pedri D; Rambow F; Makhzami S; Christiaens V; Ceyssens F; Ghanem G; Marine JC; Poovathingal S; Aerts S
Nat Cell Biol; 2020 Aug; 22(8):986-998. PubMed ID: 32753671
[TBL] [Abstract] [Full Text] [Related]
5. CD147 regulates melanoma metastasis via the nfat1-MMP-9 pathway.
Liu N; Qi M; Li K; Zeng W; Li J; Yin M; Liu H; Chen X; Zhang J; Peng C
Pigment Cell Melanoma Res; 2020 Sep; 33(5):731-743. PubMed ID: 32339381
[TBL] [Abstract] [Full Text] [Related]
6. Assessing potential mechanisms of arsenic-induced skin lesions and cancers: Human and in vitro evidence.
Zeng Q; Zhang A
Environ Pollut; 2020 May; 260():113919. PubMed ID: 31995775
[TBL] [Abstract] [Full Text] [Related]
7. Redox signals at the ER-mitochondria interface control melanoma progression.
Zhang X; Gibhardt CS; Will T; Stanisz H; Körbel C; Mitkovski M; Stejerean I; Cappello S; Pacheu-Grau D; Dudek J; Tahbaz N; Mina L; Simmen T; Laschke MW; Menger MD; Schön MP; Helms V; Niemeyer BA; Rehling P; Vultur A; Bogeski I
EMBO J; 2019 Aug; 38(15):e100871. PubMed ID: 31304984
[TBL] [Abstract] [Full Text] [Related]
8. An actionable axis linking nfatc2 to EZH2 controls the EMT-like program of melanoma cells.
Perotti V; Baldassari P; Molla A; Nicolini G; Bersani I; Grazia G; Benigni F; Maurichi A; Santinami M; Anichini A; Mortarini R
Oncogene; 2019 May; 38(22):4384-4396. PubMed ID: 30710146
[TBL] [Abstract] [Full Text] [Related]
9. New fusion sarcomas: histopathology and clinical significance of selected entities.
Miettinen M; Felisiak-Golabek A; Luiña Contreras A; Glod J; Kaplan RN; Killian JK; Lasota J
Hum Pathol; 2019 Apr; 86():57-65. PubMed ID: 30633925
[TBL] [Abstract] [Full Text] [Related]
10. nfat1 enhances the effects of tumor-associated macrophages on promoting malignant melanoma growth and metastasis.
Liu H; Yang L; Qi M; Zhang J
Biosci Rep; 2018 Dec; 38(6):. PubMed ID: 30459241
[TBL] [Abstract] [Full Text] [Related]
11. nfat1 Directly Regulates IL8 and MMP3 to Promote Melanoma Tumor Growth and Metastasis.
Shoshan E; Braeuer RR; Kamiya T; Mobley AK; Huang L; Vasquez ME; Velazquez-Torres G; Chakravarti N; Ivan C; Prieto V; Villares GJ; Bar-Eli M
Cancer Res; 2016 Jun; 76(11):3145-55. PubMed ID: 27013197
[TBL] [Abstract] [Full Text] [Related]
12. Gene expression analyses of primary melanomas reveal CTHRC1 as an important player in melanoma progression.
Eriksson J; Le Joncour V; Nummela P; Jahkola T; Virolainen S; Laakkonen P; Saksela O; Hölttä E
Oncotarget; 2016 Mar; 7(12):15065-92. PubMed ID: 26918341
[TBL] [Abstract] [Full Text] [Related]
13. nfatc2 is an intrinsic regulator of melanoma dedifferentiation.
Perotti V; Baldassari P; Molla A; Vegetti C; Bersani I; Maurichi A; Santinami M; Anichini A; Mortarini R
Oncogene; 2016 Jun; 35(22):2862-72. PubMed ID: 26387540
[TBL] [Abstract] [Full Text] [Related]
14. Incidental Melanocytic Nevi in Hemorrhoidectomy Specimens.
Val-Bernal JF; Mayorga M; Val D
Am J Dermatopathol; 2016 Apr; 38(4):278-82. PubMed ID: 26332535
[TBL] [Abstract] [Full Text] [Related]
15. Cutaneous syncytial myoepithelioma: clinicopathologic characterization in a series of 38 cases.
Jo VY; Antonescu CR; Zhang L; Dal Cin P; Hornick JL; Fletcher CD
Am J Surg Pathol; 2013 May; 37(5):710-8. PubMed ID: 23588365
[TBL] [Abstract] [Full Text] [Related]
16. Galectin-3 contributes to melanoma growth and metastasis via regulation of nfat1 and autotaxin.
Braeuer RR; Zigler M; Kamiya T; Dobroff AS; Huang L; Choi W; McConkey DJ; Shoshan E; Mobley AK; Song R; Raz A; Bar-Eli M
Cancer Res; 2012 Nov; 72(22):5757-66. PubMed ID: 22986745
[TBL] [Abstract] [Full Text] [Related]
17. nfatc2 is a potential therapeutic target in human melanoma.
Perotti V; Baldassari P; Bersani I; Molla A; Vegetti C; Tassi E; Dal Col J; Dolcetti R; Anichini A; Mortarini R
J Invest Dermatol; 2012 Nov; 132(11):2652-60. PubMed ID: 22718120
[TBL] [Abstract] [Full Text] [Related]
18. Clinical trials of a mouse-human chimeric anti-CD20 monoclonal antibody (rituximab) for B cell non-Hodgkin's lymphoma in Japan.
Tobinai K
Cancer Chemother Pharmacol; 2001 Aug; 48 Suppl 1():S85-90. PubMed ID: 11587374
[TBL] [Abstract] [Full Text] [Related]
